GO:0001774 microglial cell activation: Inflammatory Reprogramming, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001774 microglial cell activation is defined as the change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
• Microglial activation is an early, energy-demanding process driven by rapid glycolytic reprogramming that supports inflammatory cytokine production.
• Receptor systems such as TREM2, PPARγ, CD36, and adiponectin/AdipoR1 shape the balance between protective and detrimental microglial states.
• Exercise and metabolic interventions can suppress neuroinflammation by shifting microglial polarization and reducing complement-mediated synaptic phagocytosis.
• Dysregulated microglial activation contributes to Alzheimer's disease, multiple sclerosis, Parkinson's disease, retinal degeneration, and diabetes-associated hippocampal neuroinflammation.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal testing of genes controlling microglial activation.
Description
Microglial cell activation (GO:0001774) is the biological process by which microglia, the resident immune cells of the central nervous system, change their morphology and behavior in response to cytokines, chemokines, cellular ligands, or soluble factors. This process is fundamental to brain surveillance, synaptic remodeling, and host defense, but when chronically engaged it becomes a driver of neuroinflammatory injury. Understanding the molecular control of microglial activation is therefore central to neuroimmunology and to the development of therapies for neurodegenerative and psychiatric disorders.
microglial cell activation At A Glance
| GO ID | GO:0001774 |
|---|---|
| GO term | microglial cell activation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Morphological and behavioral transition of microglia in response to cytokines, chemokines, cellular ligands, or soluble factors |
| Definition source | QuickGO |
| Related cell type | Microglial cell |
| Key triggers | Cytokines, chemokines, cellular ligands, soluble factors |
| Disease relevance | Neurodegeneration, neuroinflammation, multiple sclerosis, retinal degeneration |
What Is GO:0001774?
GO:0001774 microglial cell activation describes the change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. It encompasses the transition from a ramified, surveillant state to an activated state with altered gene expression, metabolism, and effector functions.
Why Is microglial cell activation Important in Cell Biology?
Microglial activation is a central node in neuroinflammation and is mechanistically linked to Alzheimer's disease, multiple sclerosis, Parkinson's disease, retinal degeneration, and stress-related hippocampal pathology. Because activated microglia can be either protective or harmful depending on context, identifying the genes and metabolic pathways that control this transition is essential for rational therapeutic targeting.
• Controls the earliest innate immune response in the central nervous system.
• Regulates synaptic pruning and complement-mediated phagocytosis.
• Drives inflammatory cytokine production through glycolytic reprogramming.
• Modulates Alzheimer's disease progression and amyloid-related neuroinflammation.
• Contributes to multiple sclerosis lesion pathology and hormone-sensitive inflammatory responses.
• Influences retinal degeneration through TREM2-PPARγ-CD36 signaling.
• Links diabetes-associated metabolic stress to hippocampal neuroinflammation via KLK8/HGF/Met.
• Is shifted toward M2-like states by exercise through adiponectin/AdipoR1.
• Provides a therapeutic target for suppressing neuroinflammation.
• Offers a tractable process for CRISPR-based causal gene discovery.
What Happens During microglial cell activation?
Trigger recognition and receptor engagement
In simple terms: Microglia first sense danger or immune signals through surface receptors.
Microglial activation begins when microglia encounter cytokines, chemokines, cellular ligands, or soluble factors that engage surface receptors and initiate intracellular signaling. Receptors such as TREM2 and AdipoR1 transduce these cues into transcriptional and metabolic programs that define the activated state.
Early glycolytic reprogramming
In simple terms: Activated microglia quickly switch their energy use to support inflammation.
Early glycolytic reprogramming controls microglial inflammatory activation, providing the metabolic flux required for cytokine production and effector functions. This metabolic shift is an early and causal step rather than a late consequence of activation.
Morphological transition and polarization
In simple terms: Microglia change shape and adopt different functional states.
Activation involves a change in morphology and behavior, including the shift between M1-like pro-inflammatory and M2-like resolving phenotypes. Exercise and adiponectin/AdipoR1 signaling can shift this balance toward M2-like states in the hippocampus.
Effector functions: cytokines, phagocytosis, and synaptic remodeling
In simple terms: Activated microglia release signals and prune synapses.
Activated microglia produce inflammatory mediators and can execute complement-mediated synaptic phagocytosis, a process suppressed by exercise-induced CD55 upregulation in Parkinson's disease models. TREM2-dependent activation protects photoreceptors during retinal degeneration via PPARγ and CD36.
Resolution or chronic persistence
In simple terms: Activation can resolve or become chronic and harmful.
When the triggering stimulus is cleared, microglia can return to a surveillant state; persistent activation, however, sustains neuroinflammation and contributes to disease progression. Exercise suppresses neuroinflammation and alleviates Alzheimer's disease-related pathology in part by modulating this persistence.
Key Genes Involved in GO:0001774 microglial cell activation
The following genes and proteins are experimentally implicated in the control or consequences of microglial cell activation (GO:0001774).
| Gene | Major Role | Research Relevance |
|---|---|---|
| TREM2 | Receptor controlling microglial activation and photoreceptor protection | Retinal degeneration models; PPARγ/CD36 signaling |
| PPARγ | Nuclear receptor downstream of TREM2 | Mediates protective microglial activation |
| CD36 | Scavenger receptor in TREM2-PPARγ axis | Retinal degeneration and lipid handling |
| AdipoR1 | Adiponectin receptor shifting M1/M2 balance | Exercise-induced suppression of hippocampal neuroinflammation |
| CD55 | Complement regulator suppressing synaptic phagocytosis | Exercise training in Parkinson's disease models |
| KLK8 | Serine protease upstream of HGF/Met | Diabetes-associated hippocampal neuroinflammation |
| HGF | Growth factor ligand in KLK8/Met axis | Neuroinflammation in diabetes models |
| Met | Receptor tyrosine kinase for HGF | Diabetes-associated hippocampal neuroinflammation |
| IL-1β | Pro-inflammatory cytokine | Readout of microglial inflammatory activation |
| TNF-α | Pro-inflammatory cytokine | Readout of microglial inflammatory activation |
| IL-6 | Pro-inflammatory cytokine | Readout of microglial inflammatory activation |
| iNOS | M1-like effector enzyme | Marker of pro-inflammatory polarization |
| Arg1 | M2-like effector enzyme | Marker of resolving polarization |
| BDNF | Neurotrophic factor linked to microglial states | Exercise and neuroinflammation studies |
| Aβ | Amyloid-beta peptide | Alzheimer's disease neuroinflammation |
| C1q | Complement component in synaptic pruning | Complement-mediated phagocytosis |
| C3 | Complement component in synaptic pruning | Complement-mediated phagocytosis |
How Is microglial cell activation Regulated?
Microglial activation is regulated at the metabolic and receptor level. Early glycolytic reprogramming acts as a control point for inflammatory activation, such that interfering with this switch alters cytokine output. Receptor-mediated regulation by TREM2, PPARγ, and CD36 determines whether activation is protective or detrimental in the retina. Adiponectin/AdipoR1 signaling shifts the M1/M2 balance and is engaged by exercise to suppress hippocampal neuroinflammation. Complement regulation by CD55 restrains synaptic phagocytosis during exercise in Parkinson's disease models. Hormonal signals also modulate microglial activation, with relevance to multiple sclerosis.
microglial cell activation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TREM2 | Retinal degeneration | Knockout and knock-in mouse models |
| AdipoR1 | Stress-induced hippocampal neuroinflammation | Overexpression and knockout mice with exercise intervention |
| CD55 | Parkinson's disease synaptic phagocytosis | Overexpression and knockout models with exercise training |
| KLK8 | Diabetes-associated hippocampal neuroinflammation | Knockout and point-mutation models |
| PPARγ | Retinal degeneration | Conditional knockout and agonist-treated models |
Alzheimer's disease
Exercise suppresses neuroinflammation and alleviates Alzheimer's disease-related pathology, implicating microglial activation as a modifiable driver of disease progression. Amyloid-beta and inflammatory cytokines are central to this process.
Multiple sclerosis
Hormone regulation of microglial cell activation is relevant to multiple sclerosis, where inflammatory microglial responses contribute to lesion pathology.
Parkinson's disease and retinal degeneration
Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease models, while TREM2-dependent microglial activation protects photoreceptors during retinal degeneration via PPARγ and CD36.
Diabetes-associated hippocampal neuroinflammation
The KLK8/HGF/Met signaling pathway mediates diabetes-associated hippocampal neuroinflammation, linking metabolic disease to microglial activation.
From microglial cell activation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for microglial activation? | CRISPR knockout in microglial cell lines or primary microglia |
| Does a disease-associated variant alter activation? | CRISPR point-mutation knock-in |
| Does a protective allele enhance microglial function? | CRISPR knock-in of the variant |
| Where and when is the protein expressed during activation? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator suppress neuroinflammation? | CRISPR overexpression or lentiviral overexpression |
| Which genes control the M1/M2 balance? | CRISPR library screening with polarization readouts |
How to Study the microglial cell activation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional program of activation | Gene discovery in microglial activation |
| Glycolytic flux assay | Early metabolic reprogramming | Testing metabolic control of inflammation |
| ELISA | Cytokine secretion | Quantifying IL-1β, TNF-α, IL-6 output |
| Flow cytometry | M1/M2 marker expression | Polarization balance after exercise or treatment |
| Confocal imaging | Morphology and phagocytosis | Synaptic pruning and CD55 function |
| Western blot | Signaling pathway activation | KLK8/HGF/Met and TREM2-PPARγ-CD36 axes |
| CRISPR library screening | Causal gene identification | Discovery of regulators of microglial activation |
| Behavioral testing | Neuroinflammation-linked phenotypes | Exercise and Alzheimer's disease models |
Transcriptomic profiling of activation states
RNA sequencing of microglia before and after exposure to cytokines, chemokines, cellular ligands, or soluble factors identifies the gene programs that define activation.
Metabolic flux analysis
Measurements of glycolysis and oxidative phosphorylation reveal the early metabolic reprogramming that controls inflammatory activation.
Morphology and phagocytosis imaging
Time-lapse and confocal imaging quantify the morphological transition and complement-mediated synaptic phagocytosis that characterize activation.
Cytokine and polarization readouts
ELISA and flow cytometry for IL-1β, TNF-α, IL-6, iNOS, and Arg1 quantify the functional output of microglial activation and M1/M2 balance.
How CRISPR Can Be Used to Study GO:0001774 microglial cell activation
Knockout
CRISPR knockout of candidate genes such as TREM2, AdipoR1, or KLK8 in microglial cells tests whether the gene is required for activation, cytokine production, or polarization.
Point Mutation
CRISPR point-mutation knock-in introduces disease-associated variants to determine whether a single amino acid change alters microglial activation or downstream signaling.
Knock-in
CRISPR knock-in of reporters or protective alleles enables tracking of activation states and testing of allele-specific effects on microglial behavior.
Overexpression
CRISPR overexpression of regulators such as CD55 or AdipoR1 tests whether increasing their levels suppresses neuroinflammation and shifts microglial polarization.
How EDITGENE Supports microglial cell activation Research
Researchers studying microglial cell activation-related genes often need to determine whether a candidate gene is causally involved in the morphological and behavioral transition defined by GO:0001774, rather than merely correlated with it. EDITGENE provides the CRISPR models and screening services required to establish causality.
Contact EDITGENE today to design your custom CRISPR model for microglial cell activation research.
Frequently Asked Questions About microglial cell activation
What is microglial cell activation GO:0001774?
It is the change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
What genes are involved in microglial cell activation?
Genes include TREM2, PPARγ, CD36, AdipoR1, CD55, KLK8, HGF, and Met, among others.
Why is microglial activation important in Alzheimer's disease?
Exercise suppresses neuroinflammation and alleviates Alzheimer's disease-related pathology, indicating that microglial activation is a modifiable driver of disease.
How does metabolism control microglial activation?
Early glycolytic reprogramming controls microglial inflammatory activation and is required for cytokine production.
What is the role of TREM2 in microglial activation?
TREM2-dependent activation protects photoreceptors during retinal degeneration via PPARγ and CD36.
Can exercise change microglial activation?
Yes, exercise shifts the M1/M2 balance through adiponectin/AdipoR1 and upregulates CD55 to suppress complement-mediated synaptic phagocytosis.
What methods are used to study microglial activation?
RNA-seq, glycolytic flux assays, ELISA, flow cytometry, confocal imaging, and CRISPR screening are commonly used.
How do CRISPR knockouts help study microglial activation?
Knockouts test whether a candidate gene is required for activation, cytokine output, or polarization.
What diseases are linked to microglial activation?
Alzheimer's disease, multiple sclerosis, Parkinson's disease, retinal degeneration, and diabetes-associated hippocampal neuroinflammation.
What is the difference between M1 and M2 microglia?
M1-like microglia are pro-inflammatory, while M2-like microglia are resolving; the balance is regulated by pathways such as adiponectin/AdipoR1.
Conclusion
GO:0001774 microglial cell activation is a metabolically and receptor-controlled process that determines whether microglia protect or damage the central nervous system. Its links to Alzheimer's disease, multiple sclerosis, Parkinson's disease, retinal degeneration, and diabetes-associated neuroinflammation make it a high-value target for mechanistic and therapeutic research. CRISPR-based knockout, point-mutation, knock-in, overexpression, and library screening approaches provide the causal evidence needed to translate these findings into new interventions.
References
- 1. Cheng J et al.. 2021. Early glycolytic reprogramming controls microglial inflammatory activation.. J Neuroinflammation 18(1):129 PMID: 34107997
- 2. Zhou W et al.. 2024. TREM2-dependent activation of microglial cell protects photoreceptor cell during retinal degeneration via PPARγ and CD36.. Cell Death Dis 15(8):623 PMID: 39187498
- 3. Kettenmann H et al.. 2011. Physiology of microglia.. Physiol Rev 91(2):461-553 PMID: 21527731
- 4. Drew PD et al.. 2005. Hormone regulation of microglial cell activation: relevance to multiple sclerosis.. Brain Res Brain Res Rev 48(2):322-7 PMID: 15850670
- 5. Wang M et al.. 2023. Exercise suppresses neuroinflammation for alleviating Alzheimer's disease.. J Neuroinflammation 20(1):76 PMID: 36935511
- 6. Liu L et al.. 2024. Running exercise alleviates hippocampal neuroinflammation and shifts the balance of microglial M1/M2 polarization through adiponectin/AdipoR1 pathway activation in mice exposed to chronic unpredictable stress.. Mol Psychiatry 29(7):2031-2042 PMID: 38361125
- 7. Xu DH et al.. 2025. KLK8/HGF/Met signaling pathway mediates diabetes-associated hippocampal neuroinflammation in male mice.. Theranostics 15(13):6290-6312 PMID: 40521191
- 8. Yao H et al.. 2024. Exercise training upregulates CD55 to suppress complement-mediated synaptic phagocytosis in Parkinson's disease.. J Neuroinflammation 21(1):246 PMID: 39342308
